Skip to main content
. 2018 Sep 27;2018:4528547. doi: 10.1155/2018/4528547

Table 4.

Concentrations (mean ± SEM, U/ml) of anti-dsDNA isotypes and anti-C1q antibody in active, inactive, LN, and non-LN SLE patients and active, inactive LN patients.

Activity of SLE (N = 96) SLE with renal involvement (N = 96) Activity of LN (N = 50)
Active SLE (U/ml) Inactive SLE (U/ml) p value LN (U/ml) Non-LN (U/ml) P value Active LN (U/ml) Inactive LN (U/ml) p value
Anti-dsDNA IgG 116.66 ± 10.63 62.21 ± 11.27 0.001 95.57 ± 11.29 95.60 ± 12.17 NS 98.60 ± 13.40 88.90 ± 22.06 NS
Anti-dsDNA IgM 36.49 ± 5.99 34.20 ± 8.71 NS 26.14 ± 5.72 45.80 ± 8.16 0.037 26.61 ± 6.28 25.23 ± 11.90 NS
Anti-dsDNA IgA 44.39 ± 8.03 17.89 ± 5.61 0.003 29.45 ± 6.90 38.17 ± 8.53 NS 32.04 ± 9.44 23.13 ± 8.47 NS
Anti-C1q 29.36 ± 4.17 11.44 ± 2.79 0.000 23.07 ± 4.00 21.02 ± 4.12 NS 26.38 ± 5.52 16.62 ± 4.63 NS

SLE: systemic lupus erythematosus; LN: lupus nephritis; NS: no significance; p < 0.05, Mann–Whitney U test.